• Applied Use of BIRB 796 (Doramapimod) in Inflammation Resear

  2026-07-23

  BIRB 796 (Doramapimod) stands out as a highly selective p38α MAPK inhibitor, enabling precise control of inflammatory and apoptotic signaling in both cell-based and in vivo models. This article details hands-on workflows, breakthrough mechanistic findings, and troubleshooting strategies to maximize data reliability in inflammation and apoptosis research.

• Latrunculin A: Reversible Inhibitor of Actin Assembly in Vir

  2026-07-23

  Latrunculin A, offered by APExBIO, is a precision tool for dissecting actin cytoskeleton dynamics in cell biology and viral research. Its rapid, reversible inhibition of actin assembly enables robust, reproducible manipulation of cell morphology and motility, while recent studies extend its value to antiviral workflow optimization.

• Prestained Protein Marker: Triple Color Ladder for SDS-PAGE

  2026-07-22

  The Prestained Protein Marker (Triple color, EDTA free, 10-250 kDa) from APExBIO delivers vivid, multi-color bands for intuitive monitoring and accurate molecular weight estimation across SDS-PAGE, Western blot, and advanced fluorescent workflows. Its EDTA-free, triple-dye formulation ensures seamless compatibility with modern applications like Phosbind gels and fluorescent imaging—unlocking reproducibility and troubleshooting flexibility beyond traditional protein ladders.

• Isotope-Diluted UHPLC–MS/MS for Quantifying Methylated Purin

  2026-07-22

  Zhang et al. developed a highly sensitive, stable isotope-diluted UHPLC–MS/MS platform to accurately quantify ten methylated purine nucleosides in cells, including 2'-O-Methyladenosine. This methodological advance enables robust intracellular measurements, supporting biomarker discovery and mechanistic studies in RNA modification biology.

• Oleanolic Acid-Induced Liver Injury via FXR-Mediated Bile Ac

  2026-07-21

  This study reveals that oleanolic acid (OA) impairs liver function by disrupting hepatocyte tight junctions and suppressing FXR-regulated bile acid transporters, leading to cholestatic injury. The findings clarify the mechanistic role of the farnesoid X receptor (FXR) and its downstream effectors in OA-induced hepatotoxicity, with practical implications for metabolic research and the modeling of drug-induced liver injury.

• ABT-199 (Venetoclax): Precision Apoptosis in Hematologic Res

  2026-07-21

  ABT-199 (Venetoclax) delivers unmatched selectivity for Bcl-2, enabling reproducible, high-sensitivity apoptosis assays in models of hematologic malignancy. This guide translates the latest epigenetic and mechanistic advances into actionable workflows, troubleshooting strategies, and comparative insights for bench researchers.

• ECL Chemiluminescent Substrate Detection Kit (Enhanced) in P

  2026-07-20

  The ECL Chemiluminescent Substrate Detection Kit (Enhanced) addresses the need for highly sensitive and low-background detection of HRP-labeled antibodies and their antigens in western blot chemiluminescence detection. It is best suited for applications requiring reliable signal amplification and quantification of low-abundance proteins, but is not intended for non-HRP-based detection systems or workflows outside chemiluminescent western blotting.

• Leucomycin (Kitasamycin): Applied Workflows in Translational

  2026-07-20

  Leucomycin (kitasamycin) stands out as a robust tool for translational inhibition and macrolide resistance research, offering high stability and broad-spectrum activity. This guide unpacks advanced workflows, protocol parameters, and troubleshooting strategies that maximize experimental reproducibility and data quality using APExBIO's high-purity Leucomycin.

• Targeted mRNA Nanoparticles Restore BBB After Ischemic Strok

  2026-07-19

  This study demonstrates that targeted mRNA-loaded lipid nanoparticles can modulate microglial polarization to promote blood–brain barrier repair after ischemic stroke. The findings suggest a promising, mechanism-driven therapeutic strategy for mitigating neuroinflammation and improving neurological recovery.

• Dihydroartemisinin: Applied Workflows for mTOR and Malaria R

  2026-07-18

  Dihydroartemisinin, a leading Artemisia plant extract, delivers precision and flexibility in malaria and mTOR signaling pathway studies, thanks to its robust solubility and high purity. Explore stepwise protocols, troubleshooting strategies, and comparative insights to maximize reproducibility and data clarity in advanced cell-based and antiplasmodial assays.

• Applied Protocols with Salvianolic acid B in Fibrosis Resear

  2026-07-17

  Salvianolic acid B (Dan Shen Suan B) is redefining pulmonary fibrosis research by precisely targeting LH2-driven collagen cross-linking. This guide translates breakthrough findings into actionable workflows, advanced troubleshooting, and comparative advantages for fibrotic disease modeling.

• IL-36R-Driven NETosis in Psoriasis: Mechanisms and Detection

  2026-07-17

  This article examines the mechanistic insights from Zhang et al. (2024), who revealed how TLR and purinergic signaling converge to drive neutrophil extracellular trap (NET) formation via the IL-36/IL-36R axis in psoriasis. The findings highlight new molecular targets for therapeutic intervention and provide methodological guidance for immunofluorescence-based detection of NETosis and inflammatory mediators in cutaneous disease models.

• Ovarian Morphology Reveals Redox and Apoptosis Coordination

  2026-07-16

  This study demonstrates that stratifying bovine ovaries by detailed morphological criteria uncovers coordinated redox imbalance and apoptosis across ovarian tissue, follicular fluid, and granulosa cells. The approach provides a practical means to reduce biological variability in cattle ART research and highlights granulosa cells as particularly sensitive indicators of ovarian functional state.

• Phenothiazines Enhance Macrophage Antibacterial Defense via

  2026-07-16

  Qiu et al. (2025) reveal that phenothiazines, a class of dopamine D2 receptor inhibitors, boost macrophage antibacterial activity by promoting autophagy and reactive oxygen species (ROS) production. These findings offer mechanistic insights into host-directed therapies as alternatives to conventional antibiotics in the context of rising antimicrobial resistance.

• Cinoxacin: Mechanism, Spectrum, and Pharmacokinetics in UTI

  2026-07-15

  This article examines the advances presented in Scavone et al.'s foundational study on Cinoxacin, a quinolone antibiotic with rapid oral absorption and robust activity against Gram-negative urinary pathogens. The paper's nuanced analysis of pharmacokinetics, resistance, and clinical implications informs translational research on urinary tract infections and antibiotic resistance.

461 records 11/31 page Previous Next First page 上5页 1112131415 下5页 Last page